Tate & Lyle Share Discussion Threads

[maurillac] 04/2/2014 13:39

so up 2% against a falling market. very good - anyone know why ?
gla
m

[philo124] 31/1/2014 08:53

Not sure bout my holding in this.

[maurillac] 30/1/2014 10:55

well ive had a few for my isa as i think the risk/reward is good at this level and a reasonable yield is on offer (better than the high street anyway !)
gla
m

[asmagliocco] 08/1/2014 09:57

Thing is, TATE knows about such issues (hence for example the strong moves into Stevia plant products - a sweetener as natural as sugar) and will adjust its production to suit changing trends. Folks who care about their health will either switch or cut down on sugary foods or the number of tsps in their tea... Meanwhile humans are a sweet-toothed race (!) and I cannot immagine demand declining that much.

[pugugly] 08/1/2014 09:10

With Sugar now being considered by most of the medical profession as a major cause of Diabetes and obesity could Tate be in a long term declining market ??

If so potentailly a long term Sell - only possible support the dividend but for how long ??

[crabbeng] 30/12/2013 14:40

Useful divi at the end of the week, I'll be adding more once clear of 820

[dolgyn] 07/11/2013 17:16

not for long

[asmagliocco] 07/11/2013 13:12

Encouraging report in that it's not as bad as some expected perhaps? Good to see the 800s again...

[skinny] 15/10/2013 07:15

Berenberg Buy 758.00 758.00 - 900.00 Reiterates

[philo124] 07/10/2013 08:50

Questor also wrote up.

[skinny] 07/10/2013 08:46

Citigroup Buy 745.00 745.00 1,000.00 900.00 Reiterates

Deutsche Bank Buy 745.00 745.00 1,030.00 1,030.00 Reiterates

Societe Generale Buy 738.00 745.00 900.00 865.00 Upgrades

Numis Add 735.75 745.00 884.00 884.00 Reiterates

[skinny] 04/10/2013 10:07

I didn't think there was much interest for these.

I've had a dabble this morning.



Trading Update

Tate & Lyle issues the following trading update for the six months ended 30 September 2013 ahead of the announcement of Half Year Results on Thursday 7 November 2013.

OPERATING PERFORMANCE – CONTINUING OPERATIONS

The Group's performance in the second quarter was broadly in line with our expectations. Adjusted1 operating profit for the Group for the first half is expected to be slightly lower than the comparative period, largely driven by softness in the US beverage sector as a result of the cold spring and slow start to the summer which has affected sweetener volumes in both divisions.

In Speciality Food Ingredients, volume growth is expected to be in line with the wider speciality food ingredients market with strong volume growth in emerging markets and Europe, partially offset by slightly lower volumes in the US. We saw strong demand for our texturant and fibre ingredients, particularly in Asia Pacific and Latin America, but softness in the US beverage sector held back volume growth across our higher margin speciality sweeteners. This, together with lower selling prices for SPLENDA® Sucralose, is expected to result in operating profit in this division being broadly in line with the prior year period in constant currency.

Within Bulk Ingredients, operating profit is expected to be somewhat lower than the comparative period driven by lower US bulk liquid sweetener volumes. During the second quarter, we largely mitigated the increased costs associated with poor end of season corn quality and resultant lower starch production yields, and the significant decrease in the corn price.

OUTLOOK

In Speciality Food Ingredients, we expect to deliver growth in volumes, sales and profits across all regions for the full year.

Within Bulk Ingredients, in North America we expect solid demand for liquid sweeteners and stable demand for our other products. In Europe, lower corn prices are expected to more than offset the impact of lower sugar prices on isoglucose margins. Consequently, we anticipate this division delivering a stronger performance during the second half than the same period last year, and full year profits to be more evenly distributed between the first and second half.

Our profits remain sensitive to fluctuations in foreign currency particularly the US dollar to sterling exchange rate. In addition, as usual, the outcome of the calendar year sweetener pricing rounds will influence performance in the final quarter of the financial year.

Overall, we expect to deliver another year of profitable growth.

1 Continuing operations: before exceptional items and amortisation of intangible assets acquired through business combinations

END



Davy Research Neutral 737.00 - - Reiterates

Investec Buy 737.00 825.00 825.00 Reiterates

03 Oct 13 Deutsche Bank Buy 737.00 1,050.00 1,030.00 Reiterates

02 Oct 13 Canaccord Genuity Buy 737.00 900.00 900.00 Reiterates

[philo124] 04/10/2013 10:01

Trading statement mixed. Canaccord 900p

[mj19] 20/9/2013 08:58

numis cuts to neutral today £8 target price....

every day someone cuts and adds like a yo yo

[philo124] 12/9/2013 09:21

Canaccord 900p target Buy.

[high yields] 10/9/2013 05:52

There is a support level around 750, and the next one at 650 ?!

[carterone] 09/9/2013 21:41

UBS downgrade to sell

[irenekent] 09/9/2013 16:56

Why the sudden fall?

[mj19] 18/7/2013 09:35

down today 839

soc gen cuts to hold from buy

[mj19] 18/7/2013 09:35

down today 839

soc gen cuts to hold from buy

[share cadaver] 18/6/2013 14:57

this is an old favourite of mine, been in it over 3yrs now. got on board at £4 and will be holding another few yrs till we see £15

[leeson31] 11/6/2013 16:37

wow, wonder if many ppl got in sub 800p...

[ygor706] 09/6/2013 08:54

The bottom of the 5 year trend line is around 730p but the share price is riding the base line of the Bollinger chart which it doesn't do very often. Therefore bought a few more of these on Friday.

[ontheropes] 23/5/2013 22:09

23/5/13 - Deutsche New Target price 1050p